(Q51740649)

11 April 2018

title

Clinical and experimental features of MuSK antibody positive MG in Japan. (English)

1 reference

11 April 2018

1 reference

K Ohta

1

1 reference

11 April 2018

K Shigemoto

2

1 reference

11 April 2018

A Fujinami

3

1 reference

11 April 2018

N Maruyama

4

1 reference

11 April 2018

T Konishi

5

1 reference

11 April 2018

M Ohta

6

1 reference

11 April 2018

publication date

1 September 2007

1 reference

11 April 2018

European Journal of Neurology

published in

1 reference

11 April 2018

volume

14

1 reference

11 April 2018

issue

9

1 reference

11 April 2018

page(s)

1029-1034

1 reference

11 April 2018

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01870.X

Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01870.X

Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01870.X

Clinical aspects of MuSK antibody positive seronegative MG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01870.X

Detection and characterization of MuSK antibodies in seronegative myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01870.X

Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01870.X

Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01870.X

MuSK antibody-positive, seronegative myasthenia gravis in Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01870.X

Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01870.X

Induction of myasthenia by immunization against muscle-specific kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01870.X

Tyrosine phosphorylation of the muscle-specific kinase is exclusively induced by acetylcholine receptor-aggregating agrin fragments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01870.X

Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01870.X

The features of myasthenia gravis with autoantibodies to MuSK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01870.X

Thymus changes in anti-MuSK-positive and -negative myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01870.X

Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01870.X

Anti-MuSK antibodies: correlation with myasthenia gravis severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01870.X

Are MuSK antibodies the primary cause of myasthenic symptoms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01870.X

Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01870.X

Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01870.X

MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01870.X

MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01870.X

Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2007.01870.X

10.1111/J.1468-1331.2007.01870.X

21 January 2018

Identifiers

DOI

1 reference

11 April 2018

1 reference

11 April 2018